Advantages and disadvantages of glycomacropeptide therapy for phenylketonuria compared with traditional diet therapy

Abstract

Phenylketonuria is an autosomal recessive disease for which there is no cure, which has a lasting adverse impact on patients' lives. At present, only two treatment methods have been widely used in clinical practice, one is traditional long-term low protein diet therapy, the other is glycomacropeptide therapy. However, the two methods have defects such as poor food palatability, poor patient compliance, and unclear immunity. Therefore, it is particularly important to explore the potential advantages and complementary advantages of the two widely used methods to improve patients' lives. This paper mainly applies the research method of literature review to explore and analyze the advantages and disadvantages of traditional diet therapy and glycomacropeptide therapy. The conclusion of this study is that in order to benefit the existing PKU patients to a greater extent and improve their quality of life and treatment effect, traditional diet therapy should be given priority, supplemented by glycomacropeptide therapy, and the two dietary plans should be implemented in parallel, so as to achieve better results. In addition, do not use the two treatment schemes in isolation.